FR2730637B1
(fr)
|
1995-02-17 |
1997-03-28 |
Rhone Poulenc Rorer Sa |
Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
|
IL122290A0
(en)
*
|
1995-06-07 |
1998-04-05 |
Inex Pharmaceuticals Corp |
Lipid-nucleic acid complex its preparation and use
|
US7422902B1
(en)
|
1995-06-07 |
2008-09-09 |
The University Of British Columbia |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
FR2739292B1
(fr)
*
|
1995-09-28 |
1997-10-31 |
Rhone Poulenc Rorer Sa |
Composition pharmaceutique utile pour la transfection d'acides nucleiques et ses utilisations
|
GB2324534B
(en)
*
|
1996-01-06 |
2000-05-10 |
Danbiosyst Uk |
Composition for delivery of nucleic acid to a cell
|
EP0934082B1
(de)
*
|
1996-10-23 |
2002-07-17 |
SKW Trostberg Aktiengesellschaft |
Verfahren zur herstellung von biologisch aktiven polymernanopartikel-nucleinsäure-konjugaten
|
US6071533A
(en)
|
1996-11-12 |
2000-06-06 |
The Regents Of The University Of California |
Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery
|
US6884430B1
(en)
|
1997-02-10 |
2005-04-26 |
Aventis Pharma S.A. |
Formulation of stabilized cationic transfection agent(s) /nucleic acid particles
|
EP0973928B1
(en)
|
1997-03-11 |
2010-05-05 |
Regents Of The University Of Minnesota |
Dna-based transposon system for the introduction of nucleic acid into dna of a cell
|
US5912225A
(en)
|
1997-04-14 |
1999-06-15 |
Johns Hopkins Univ. School Of Medicine |
Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine ester) compounds, compositions, articles and methods for making and using the same
|
US6524613B1
(en)
|
1997-04-30 |
2003-02-25 |
Regents Of The University Of Minnesota |
Hepatocellular chimeraplasty
|
DE19726186A1
(de)
*
|
1997-06-20 |
1998-12-24 |
Boehringer Ingelheim Int |
Komplexe für den Transport von Nukleinsäure in höhere eukaryotische Zellen
|
KR100615117B1
(ko)
|
1997-09-15 |
2006-08-22 |
제네틱 이뮤너티, 엘엘씨. |
피부의 항원제시 세포에 유전자를 전달하는 방법
|
US20020022034A1
(en)
*
|
1997-09-15 |
2002-02-21 |
Julianna Lisziewicz |
Therapeutic DNA vaccination
|
DE19743135A1
(de)
*
|
1997-09-30 |
1999-04-01 |
Hoechst Marion Roussel De Gmbh |
Biologisch verträgliche niedermolekular Polyethylenimine
|
WO1999065531A1
(en)
*
|
1998-06-18 |
1999-12-23 |
Johns Hopkins University School Of Medicine |
Polymers for delivery of nucleic acids
|
US6916490B1
(en)
|
1998-07-23 |
2005-07-12 |
UAB Research Center |
Controlled release of bioactive substances
|
EP1044679B1
(en)
*
|
1998-11-02 |
2012-12-26 |
Terumo Kabushiki Kaisha |
Stable Liposomes for Targeted Drug Delivery
|
US7160682B2
(en)
*
|
1998-11-13 |
2007-01-09 |
Regents Of The University Of Minnesota |
Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell
|
ATE338540T1
(de)
*
|
1999-04-02 |
2006-09-15 |
Res Dev Foundation |
Polyethyleneimine: dns-formulierungen für die aerosol-verabreichung
|
US6770740B1
(en)
|
1999-07-13 |
2004-08-03 |
The Regents Of The University Of Michigan |
Crosslinked DNA condensate compositions and gene delivery methods
|
FR2797402B1
(fr)
|
1999-07-15 |
2004-03-12 |
Biomerieux Stelhys |
Utilisation d'un polypeptide pour detecter, prevenir ou traiter un etat pathologique associe a une maladie degenerative, neurologique ou autoimmune
|
DE19960206A1
(de)
*
|
1999-12-14 |
2001-07-19 |
Frank Czubayko |
Komplexierung von RNS mit Polyethyleniminen zur deren Stabilisierung und zellulären Einschleusung
|
EP1156832A1
(en)
|
1999-12-28 |
2001-11-28 |
Transgene S.A. |
Use of lithium (li?+ ) for the preparation of a composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy
|
JP2003519199A
(ja)
*
|
1999-12-30 |
2003-06-17 |
ノバルティス アクチエンゲゼルシャフト |
遺伝子治療のための新規なコロイド合成ベクター
|
FR2805271B1
(fr)
*
|
2000-02-18 |
2002-04-26 |
Aventis Pharma Sa |
Procede de preparation de polyalkylenimines fonctionnalises, compositions les contenant et leurs utilisations
|
HUP0303379A3
(en)
*
|
2000-09-05 |
2004-03-01 |
Gencell Sa |
Acid-sensitive compounds, use thereof and pharmaceutical compositions containing them
|
FR2813605B1
(fr)
*
|
2000-09-05 |
2002-10-18 |
Aventis Pharma Sa |
Composes acidosensibles, leur preparation et utilisations
|
FR2814370B1
(fr)
|
2000-09-22 |
2004-08-20 |
Centre Nat Rech Scient |
Utilisation d'un complexe acide nucleique/pei pour le ciblage de cellules souches du cerveau
|
DE10145134A1
(de)
*
|
2000-10-09 |
2002-05-16 |
Bayer Ag |
Komplexe zur Einführung von Nukleinsäuren in Zellen
|
AU2001289943A1
(en)
*
|
2000-10-09 |
2002-04-22 |
Bayer Aktiengesellschaft |
Complexes for transferring nucleic acids into cells
|
US20020091242A1
(en)
|
2000-10-11 |
2002-07-11 |
Michel Bessodes |
Acid-sensitive compounds, their preparation and uses
|
CA2437555A1
(en)
*
|
2001-02-01 |
2002-08-08 |
Yiyu Zou |
Stabilised polymeric aerosols for pulmonary gene delivery
|
US6652886B2
(en)
|
2001-02-16 |
2003-11-25 |
Expression Genetics |
Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
|
US20040234586A1
(en)
*
|
2001-06-11 |
2004-11-25 |
Sylvain Meloche |
Compositions and methods for enhancing nucleic acid transfer into cells
|
AU2002339224B2
(en)
|
2001-09-14 |
2008-10-09 |
Kuros Us Llc |
Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
|
JP2005508396A
(ja)
*
|
2001-11-02 |
2005-03-31 |
イントラディグム、コーポレイション |
核酸送達ビヒクルのための治療方法
|
HUE036402T2
(hu)
|
2002-01-17 |
2018-07-30 |
Alfa Laval Corp Ab |
Merülõpárologtató, amely lemezes hõcserélõt és hengeres házat tartalmaz, ahol a lemezes hõcserélõ el van helyezve
|
WO2003089618A2
(en)
*
|
2002-04-22 |
2003-10-30 |
Regents Of The University Of Minnesota |
Transposon system and methods of use
|
WO2003099225A2
(en)
|
2002-05-24 |
2003-12-04 |
Mirus Corporation |
Compositions for delivering nucleic acids to cells
|
ATE485031T1
(de)
|
2002-06-28 |
2010-11-15 |
Protiva Biotherapeutics Inc |
Verfahren und vorrichtung zur herstellung von liposomen
|
CA2498777C
(en)
*
|
2002-09-13 |
2015-01-13 |
Replicor, Inc. |
Non-sequence complementary antiviral oligonucleotides
|
US20050196382A1
(en)
*
|
2002-09-13 |
2005-09-08 |
Replicor, Inc. |
Antiviral oligonucleotides targeting viral families
|
CA2445204C
(en)
|
2002-10-16 |
2014-08-12 |
Streck Laboratories, Inc. |
Method and device for collecting and preserving cells for analysis
|
US7153905B2
(en)
*
|
2003-03-21 |
2006-12-26 |
The General Hospital Corporation |
Hyperbranched dendron and methods of synthesis and use thereof
|
EP2567693B1
(en)
|
2003-07-16 |
2015-10-21 |
Protiva Biotherapeutics Inc. |
Lipid encapsulated interfering RNA
|
NZ592917A
(en)
|
2003-09-15 |
2012-12-21 |
Protiva Biotherapeutics Inc |
Stable polyethyleneglycol (PEG) dialkyloxypropyl (DAA) lipid conjugates
|
EP1737956A2
(en)
*
|
2004-03-01 |
2007-01-03 |
Massachusetts Institute of Technology |
Rnai-based therapeutics for allergic rhinitis and asthma
|
WO2005089123A2
(en)
*
|
2004-03-04 |
2005-09-29 |
Massachusetts Institute Of Technology |
Therapeutic anti-cancer dna
|
US20060026699A1
(en)
*
|
2004-06-04 |
2006-02-02 |
Largaespada David A |
Methods and compositions for identification of genomic sequences
|
US7799565B2
(en)
|
2004-06-07 |
2010-09-21 |
Protiva Biotherapeutics, Inc. |
Lipid encapsulated interfering RNA
|
US7745651B2
(en)
|
2004-06-07 |
2010-06-29 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods of use
|
US7807815B2
(en)
|
2004-07-02 |
2010-10-05 |
Protiva Biotherapeutics, Inc. |
Compositions comprising immunostimulatory siRNA molecules and DLinDMA or DLenDMA
|
US8101741B2
(en)
|
2005-11-02 |
2012-01-24 |
Protiva Biotherapeutics, Inc. |
Modified siRNA molecules and uses thereof
|
US7915399B2
(en)
|
2006-06-09 |
2011-03-29 |
Protiva Biotherapeutics, Inc. |
Modified siRNA molecules and uses thereof
|
US20080312174A1
(en)
*
|
2007-06-05 |
2008-12-18 |
Nitto Denko Corporation |
Water soluble crosslinked polymers
|
JP2010539245A
(ja)
*
|
2007-09-14 |
2010-12-16 |
日東電工株式会社 |
薬物担体
|
EP2047858A1
(en)
|
2007-10-10 |
2009-04-15 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Combination products for treating cancer
|
DE102008016275A1
(de)
|
2008-03-28 |
2009-11-19 |
Biontex Laboratories Gmbh |
Verbesserung von Transfektionsergebnissen nicht-viraler Genliefersysteme durch Blockierung des angeborenen Immunsystems
|
DE102007056488A1
(de)
|
2007-11-22 |
2009-07-23 |
Biontex Laboratories Gmbh |
Steigerung von Transfektionseffizienzen nicht-viraler Genliefersysteme durch Blockierung des angeborenen Immunsystems
|
WO2009065618A2
(de)
|
2007-11-22 |
2009-05-28 |
Biontex Laboratories Gmbh |
Verbesserung von transfektionsergebnissen nicht-viraler genliefersysteme durch beeinflussung des angeborenen immunsystems
|
DE102008023913A1
(de)
|
2008-05-16 |
2009-11-19 |
Biontex Laboratories Gmbh |
Verbesserung von Transfektionsergebnissen nicht-viraler Genliefersysteme durch Beeinflussung des angeborenen Immunsystems
|
GB0724253D0
(en)
|
2007-12-12 |
2008-01-30 |
Fermentas Uab |
Transfection reagent
|
US9006191B2
(en)
|
2007-12-27 |
2015-04-14 |
Protiva Biotherapeutics, Inc. |
Silencing of polo-like kinase expression using interfering RNA
|
US7687027B2
(en)
*
|
2008-02-27 |
2010-03-30 |
Becton, Dickinson And Company |
Cleaning compositions, methods and materials for reducing nucleic acid contamination
|
FR2928373B1
(fr)
|
2008-03-05 |
2010-12-31 |
Centre Nat Rech Scient |
Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
|
JP2011516094A
(ja)
|
2008-04-15 |
2011-05-26 |
プロチバ バイオセラピューティクス インコーポレイティッド |
干渉rnaを用いたcsn5遺伝子発現のサイレンシング方法
|
WO2009127060A1
(en)
|
2008-04-15 |
2009-10-22 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for nucleic acid delivery
|
EP2285969B1
(en)
*
|
2008-05-15 |
2013-01-16 |
National Research Council Of Canada |
Use of protein kinase b and valproic acid to increase heterologous gene expression in mammalian cells
|
US9139554B2
(en)
|
2008-10-09 |
2015-09-22 |
Tekmira Pharmaceuticals Corporation |
Amino lipids and methods for the delivery of nucleic acids
|
WO2010078194A1
(en)
*
|
2008-12-30 |
2010-07-08 |
Streck, Inc. |
Method for screening blood using a preservative that may be in a substantially solid state form
|
US11634747B2
(en)
*
|
2009-01-21 |
2023-04-25 |
Streck Llc |
Preservation of fetal nucleic acids in maternal plasma
|
DE102009006606A1
(de)
|
2009-01-29 |
2010-08-05 |
Philipps-Universität Marburg |
Nicht-virales Transfektionsmittel
|
NO2398912T3
(xx)
|
2009-02-18 |
2018-02-10 |
|
|
WO2010125544A1
(en)
|
2009-04-30 |
2010-11-04 |
Genetic Immunity Kft. |
Immunogenic nanomedicine composition and preparation and uses thereof
|
US8569256B2
(en)
|
2009-07-01 |
2013-10-29 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
US9018187B2
(en)
|
2009-07-01 |
2015-04-28 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
CA2767127A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for delivery of therapeutic agents to solid tumors
|
WO2011046983A2
(en)
|
2009-10-12 |
2011-04-21 |
Smith Holdings, Llc |
Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro
|
GB0917792D0
(en)
*
|
2009-10-12 |
2009-11-25 |
Fermentas Uab |
Delivery agent
|
US9856456B2
(en)
|
2009-10-12 |
2018-01-02 |
Thermo Fisher Scientific Baltics Uab |
Delivery agent
|
WO2011057184A1
(en)
|
2009-11-09 |
2011-05-12 |
Streck, Inc. |
Stabilization of rna in and extracting from intact cells within a blood sample
|
ES2640906T3
(es)
|
2010-03-24 |
2017-11-07 |
Institut National De La Sante Et De La Recherche Medicale |
Modelo primate de la familia de los cercopitécidos infectado por una cepa del VHB de genotipo humano
|
WO2011120953A1
(en)
|
2010-03-29 |
2011-10-06 |
Universite De Strasbourg |
Polymers for delivering molecules of interest
|
AU2011268146A1
(en)
|
2010-06-17 |
2013-01-10 |
Actogenix Nv |
Compositions and methods for treating inflammatory conditions
|
SI3135301T1
(en)
|
2010-06-22 |
2018-08-31 |
Onxeo |
OPTIMIZED SYSTEM OF DELIVERY AND VIVO WITH ENDOSOMOLITIC MEANS FOR KONJUGATE NUCLEIC ACIDS
|
WO2012000104A1
(en)
|
2010-06-30 |
2012-01-05 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
WO2012151391A2
(en)
|
2011-05-04 |
2012-11-08 |
Streck, Inc. |
Inactivated virus compositions and methods of preparing such compositions
|
US20140234373A1
(en)
|
2011-09-16 |
2014-08-21 |
Georfia Regents University |
Methods of Promoting Immune Tolerance
|
US20150240238A1
(en)
|
2011-11-17 |
2015-08-27 |
The Regents Of The University Of California |
Therapeutic rna switches compositions and methods of use
|
CA2856455C
(en)
|
2011-11-24 |
2022-08-23 |
Genethon |
Scalable lentiviral vector production system compatible with industrial pharmaceutical applications
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
ES2826203T3
(es)
*
|
2012-06-08 |
2021-05-17 |
Ethris Gmbh |
Suministro pulmonar de ARN mensajero
|
CN103059295B
(zh)
*
|
2012-09-26 |
2016-01-13 |
上海交通大学 |
疏水修饰的聚乙烯亚胺及其作为蛋白质载体的用途
|
DK2903652T3
(da)
|
2012-10-05 |
2022-07-04 |
Biontech Delivery Tech Gmbh |
Hydroxylerede polyaminderivater som transfektionsreagenser
|
US9677078B2
(en)
|
2012-10-08 |
2017-06-13 |
Lipocalyx Gmbh |
Carboxylated polyamine derivatives as transfection reagents
|
DE102012111891A1
(de)
*
|
2012-12-06 |
2014-06-12 |
Eberhard Karls Universität Tübingen Medizinische Fakultät |
Verbesserung der Zielfindungskapazität von Stammzellen
|
CA2917912C
(en)
|
2013-07-24 |
2019-09-17 |
Streck, Inc. |
Compositions and methods for stabilizing circulating tumor cells
|
US20160296632A1
(en)
|
2013-11-13 |
2016-10-13 |
Aequus Biopharma, Inc. |
Engineered glycoproteins and uses thereof
|
KR20170075742A
(ko)
|
2014-10-02 |
2017-07-03 |
프로티바 바이오쎄라퓨틱스, 인코포레이티드 |
B형 간염 바이러스 유전자 발현을 제거하는 조성물 및 방법
|
EP3034539A1
(en)
|
2014-12-19 |
2016-06-22 |
Ethris GmbH |
Compositions for introducing nucleic acid into cells
|
US11168351B2
(en)
|
2015-03-05 |
2021-11-09 |
Streck, Inc. |
Stabilization of nucleic acids in urine
|
BR112017023788A2
(pt)
|
2015-05-05 |
2018-10-16 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
composições de ácido nucleico?polímero catiônico e processo para a preparação de dita composição
|
WO2016197132A1
(en)
|
2015-06-04 |
2016-12-08 |
Protiva Biotherapeutics Inc. |
Treating hepatitis b virus infection using crispr
|
CN108350455A
(zh)
|
2015-07-29 |
2018-07-31 |
阿布特斯生物制药公司 |
用于使b型肝炎病毒基因表达沉默的组合物和方法
|
US20170145475A1
(en)
|
2015-11-20 |
2017-05-25 |
Streck, Inc. |
Single spin process for blood plasma separation and plasma composition including preservative
|
US10010627B2
(en)
|
2016-06-03 |
2018-07-03 |
International Business Machines Corporation |
Modified polycationic polymers
|
WO2018022991A1
(en)
|
2016-07-29 |
2018-02-01 |
Streck, Inc. |
Suspension composition for hematology analysis control
|
EP3541420A2
(en)
|
2016-11-16 |
2019-09-25 |
Immunomic Therapeutics, Inc. |
Nucleic acids for treatment of allergies
|
EP3570814B1
(en)
|
2017-01-19 |
2023-11-29 |
Universiteit Gent |
Molecular adjuvants for enhanced cytosolic delivery of active agents
|
KR102637960B1
(ko)
|
2017-04-22 |
2024-02-21 |
이뮤노믹 쎄라퓨틱스, 인크. |
개선된 lamp 구축물
|
EP3618854A1
(en)
|
2017-05-02 |
2020-03-11 |
Immunomic Therapeutics, Inc. |
Lamp (lysosomal associated membrane protein) constructs comprising cancer antigens
|
US20210261647A1
(en)
|
2018-05-15 |
2021-08-26 |
Immunomic Therapeutics, Inc |
Lamp constructs comprising allergens
|
TW202043256A
(zh)
|
2019-01-10 |
2020-12-01 |
美商健生生物科技公司 |
前列腺新抗原及其用途
|
AU2020366515A1
(en)
|
2019-10-18 |
2022-04-21 |
Immunomic Therapeutics, Inc. |
Improved lamp constructs comprising cancer antigens
|
AU2020385683A1
(en)
|
2019-11-18 |
2022-06-30 |
Janssen Biotech, Inc. |
Vaccines based on mutant CALR and JAK2 and their uses
|
WO2022009052A2
(en)
|
2020-07-06 |
2022-01-13 |
Janssen Biotech, Inc. |
Prostate neoantigens and their uses
|
WO2022009049A1
(en)
|
2020-07-06 |
2022-01-13 |
Janssen Biotech, Inc. |
Prostate neoantigens and their uses
|
EP4176087A1
(en)
|
2020-07-06 |
2023-05-10 |
Janssen Biotech, Inc. |
A method for determining responsiveness to prostate cancer treatment
|
CN112237633B
(zh)
*
|
2020-10-22 |
2023-06-27 |
林君玉 |
一种pei/on复合物及其制备方法和用途
|
AU2021385572A1
(en)
|
2020-11-25 |
2023-06-22 |
Akagera Medicines, Inc. |
Lipid nanoparticles for delivery of nucleic acids, and related methods of use
|
IL308705A
(en)
|
2021-06-08 |
2024-01-01 |
Touchlight Ip Ltd |
LENTIVIRAL vector
|
GB202108176D0
(en)
|
2021-06-08 |
2021-07-21 |
Touchlight Ip Ltd |
Vector
|
WO2023201201A1
(en)
|
2022-04-10 |
2023-10-19 |
Immunomic Therapeutics, Inc. |
Bicistronic lamp constructs comprising immune response enhancing genes and methods of use thereof
|